Facing the Challenges and Unknowns Posed by GLP-1 Receptor Agonist Medications including Eating Disorders

In this webinar Dr Brown will provide an overview of how GLP-1RAs act in the brain to increase feeling of satiety as well as reduce hedonic aspects of eating behaviour such as craving. She will also cover what is known about the role of GLP-1 in stress and mood. Assoc/Prof Piya will then provide an overview of the use of GLP-1 receptor agonists medications in Type 2 diabetes and weight management. He will overview the clinical trial data to date and address factors clinicians should take into account when patients with an eating disorder seek guidance on GLP-1 RAs.

Presenters: Associate Professor Milan Piya, Clinical Academic Endocrinologist, Western Sydney University AND Campbelltown and Camden Hospitals Research Lead –Macarthur Clinical Obesity Research Program (MCORP). Dr Robyn Brown, Senior Lecturer | Head, Behavioural Neuropharmacology Laboratory, The University of Melbourne